No Data
No Data
Edwards Lifesciences (EW) Up 19.4% Since Last Earnings Report: Can It Continue?
Following a 7.7% Decline Over Last Year, Recent Gains May Please Edwards Lifesciences Corporation (NYSE:EW) Institutional Owners
Citi Maintains Edwards Lifesciences(EW.US) With Buy Rating, Announces Target Price $83
Deutsche Bank Maintains Edwards Lifesciences(EW.US) With Buy Rating, Cuts Target Price to $85
Edwards Lifesciences: A Strong Buy on Market Expansion and Innovative Cardiovascular Solutions
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)